FDA Adverse Event Malfunction Summary report: N

SORIN S3 GAS BLENDER

MDR report key: 4564630 · Received February 25, 2015

Report

Report Number
9611109-2015-00037
Event Type
Malfunction
Date Received
February 25, 2015
Date of Event
January 30, 2015
Report Date
April 3, 2017
Manufacturer
SORIN GROUP DEUTSCHLAND
Product Code
DTX
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

(B)(4) MANUFACTURES THE S3 GAS BLENDER. THE EVENT OCCURRED IN (B)(6). THIS MEDWATCH REPORT IS BEING FILED ON BEHALF OF (B)(4). A (B)(4) FIELD SERVICE REPRESENTATIVE WAS DISPATCHED TO THE FACILITY TO INVESTIGATE. THE SERVICE REPRESENTATIVE LEARNED THAT THE USER COMPLETED THE PROCEDURE BY SWITCHING WITH O2 BOTTLE. THE SERVICE REPRESENTATIVE WAS ABLE TO REPRODUCE THE REPORTED ERROR. A LOANER UNIT WAS PROVIDED TO THE CUSTOMER AND THE FAULTY DEVICE WAS RETURNED TO (B)(4) FOR FURTHER INVESTIGATION. DURING EVALUATION AT (B)(4), THE ISSUE COULD NOT BE REPRODUCED. ALL TESTS PERFORMED WERE ERROR-FREE. A TEST RUN AND SAFETY CHECK WERE PERFORMED AND THE UNIT WAS RETURNED TO THE CUSTOMER. A REVIEW OF THE DHR DID NOT IDENTIFY ANY DEVIATIONS OR NON-CONFORMITIES RELEVANT TO THE REPORTED ISSUE.

Additional Manufacturer Narrative · 1

SORIN GROUP (B)(4) MANUFACTURES THE S5 GAS BLENDER. THE INCIDENT OCCURRED IN (B)(6). THIS MEDWATCH REPORT IS FILED ON BEHALF OF SORIN GROUP (B)(4). THE S5 GAS BLENDER IS NOT SOLD IN THE UNITED STATES BUT A SIMILAR S5 GAS BLENDER WHICH IS SOLD IN THE UNITED STATES. THE 510K # FOR THE S5 GAS BLENDER IS K101046. THE INVESTIGATION IS ONGOING. A FOLLOW UP REPORT WILL BE SENT WHEN THE INVESTIGATION IS COMPLETE.

Description of Event or Problem · 1

SORIN GROUP (B)(4) RECEIVED A REPORT THAT S3 GAS BLENDER DISPLAYED AN ERROR MESSAGE DURING A PROCEDURE. THERE WAS NO PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
134418 SORIN S3 GAS BLENDER GAS CONTROL UNIT, CARDIOPULMONARY BYPASS DTX SORIN GROUP DEUTSCHLAND 24-40-00 NA

Patients

Seq Age Sex Outcome Treatment
1 NP